DHA R&D-MRDC researchers are applying the latest regulatory guidance related to AI to better carry out their mission to develop life-saving medicines.

Pharmaceutical industry experts at Gitex Asia 2025 discuss how AI is revolutionising drug discovery, from accelerating ...

AI can speed research, but transforming how fast science progresses will require addressing deep cultural and institutional ...

GenAI offers a realistic path forward in tackling previously undruggable targets, with the potential to reshape the entire therapeutic landscape and the whole drug discovery pipeline.

Google DeepMind CEO Demis Hassabis, one of the only people in the world with a Nobel Prize for work on artificial ...

As per Vantage Market Research, the Global Artificial Intelligence in the Drug Discovery Market has been steadily growing over the years due to the growing demand for personalized medicine, the ...

Pakistan’s pharma sector is increasingly deploying artificial intelligence (AI) and advanced technologies to improve drug ...

At Google DeepMind, researchers are chasing what's called artificial general intelligence: a silicon intellect as versatile ...

This article was published by IBN, a multifaceted communications organization engaged in connecting public companies to the ...

Rakovina Therapeutics Inc. (TSX-V: RKV) (FSE: 7JO), a biopharmaceutical company advancing innovative cancer therapies through artificial intelligence (AI)-powered drug discovery, is pleased to ...

Artificial intelligence (AI) is taking over the world. The U.S. Food and Drug Administration (FDA) recently announced it would phase out animal testing in drug development in favor of other methods, ...